SeaCrest Wealth Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-106,700
| Closed | -$519K | – | 637 |
|
|
2025
Q1 | $519K | Buy |
106,700
+13,000
| +14% | +$63.2K | 0.06% | 323 |
|
|
2024
Q4 | $896K | Sell |
93,700
-25,000
| -21% | -$239K | 0.09% | 202 |
|
|
2024
Q3 | $991K | Buy |
118,700
+3,705
| +3% | +$30.9K | 0.11% | 190 |
|
|
2024
Q2 | $784K | Buy |
114,995
+18,995
| +20% | +$130K | 0.09% | 216 |
|
|
2024
Q1 | $243K | Buy |
+96,000
| New | +$243K | 0.03% | 510 |
|
|
2019
Q2 | – | Sell |
-79
| Closed | -$4K | – | 865 |
|
|
2019
Q1 | $4K | Hold |
79
| – | – | ﹤0.01% | 1767 |
|
|
2018
Q4 | $5K | Hold |
79
| – | – | ﹤0.01% | 1685 |
|
|
2018
Q3 | $5K | Sell |
79
-30
| -28% | -$1.9K | ﹤0.01% | 1850 |
|
|
2018
Q2 | $6K | Hold |
109
| – | – | ﹤0.01% | 1758 |
|
|
2018
Q1 | $6K | Hold |
109
| – | – | ﹤0.01% | 1731 |
|
|
2017
Q4 | $5K | Buy |
+109
| New | +$5K | ﹤0.01% | 1792 |
|